Innovative Technologies To Accelerate Identification Of High-Quality Clones

Cell line development (CLD) is often a race against the clock. The challenge of identifying a stable clone that produces antibodies at high yields while meeting the necessary critical quality attributes (CQAs) can feel daunting. This process is filled with obstacles, such as the need for repeated clone stability testing, multiple CQA evaluations, and efficient data management. These challenges can hinder scientific progress, delay process optimization, and impede scale-up efforts.

In this webinar, you will explore how to overcome these challenges by utilizing cutting-edge technologies from Danaher’s Life Sciences Companies. We will highlight the importance of using purpose-built, strategically selected technologies that help streamline the process of identifying high-yield, stable clones and assessing CQAs early, thus speeding up your CLD timelines.

Key Learning Objectives:

• Discover how to address bottlenecks in CHO cell line development through the New Cydem VT Automated Clone Screening System.
• Learn how to speed up the identification of charge variants during early cell line development to inform decisions throughout the process.
• Understand how adopting a data-driven approach in the lab can elevate data integration from unit operations to the enterprise.